EagleClaw Capital Managment »

Crispr Therapeutics shares owned by EagleClaw Capital Managment

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by EagleClaw Capital Managment from 13F filings

Historical chart of EagleClaw Capital Managment investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by EagleClaw Capital Managment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by EagleClaw Capital Managment

Quarter filed Position value Share count Share price at filing
2026-06-30 $930k 17k 54.54

More positions owned by EagleClaw Capital Managment

Texas Pacific Land Corp (TPL)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Palo Alto Networks (PANW)
Caterpillar (CAT)
Alphabet Cap Stk Cl C (GOOG)
Abbvie (ABBV)
JPMorgan Chase & Co. (JPM)
Eaton Corp SHS (ETN)
Landbridge Company Cl A (LB)
Wheaton Precious Metals Corp (WPM)
Grayscale Bitcoin Trust Etf Shs Rep Com Ut (GBTC)
Nike CL B (NKE)
Home Depot (HD)
Linde SHS (LIN)

View all positions for EagleClaw Capital Managment

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital World Investors
State Street Corporation
GSK
Geode Capital Management
Sr One Capital Management
Two Sigma Investments
FMR
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
EcoR1 Capital
UBS Group
Capital Research and Management Company - Division 3

View all funds holding Crispr Therapeutics